Paper Review Records
全部论文审稿周期
11 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接
89
天
Active targeting strategies for PROTAC delivery in cancer therapy: Advances, challenges, and future perspectives
作者
Meihan Liu; Yaoshu Song; Kexin Luo; Yongsheng Zhao; Hongpan Zhang展开收起
作者单位
Affiliated Hospital of North Sichuan Medical College, Nanchong, PR China; Department of Oncology, Affiliated Hospital of North Sichuan Medical College, Nanchong, PR China; Department of Thoracic Surgery, Affiliated Hospital of North Sichuan Medical College, Nanchong, PR China; North Sichuan Medical College, PR China; North Sichuan Medical College Innovation Centre for Science and Technology, PR China; Key Laboratory of Integrated Precision Diagnosis and Treatment for Solid Tumors, Sichuan Provincial Health Commission展开收起
48
天
PCSK9 in the liver metastatic niche: From cholesterol homeostasis to tumor microenvironment reprogramming
作者
Ander Martin; Helena García García; Iratxe Bañares; Abdel-Majid Khatib; Iker Badiola展开收起
作者单位
University of Bordeaux, Bordeaux Institute of Oncology (BRIC)-UMR1312, Bordeaux, France; Department of Cell Biology and Histology, University of the Basque Country, B° Sarriena sn, Leioa 48940, Spain展开收起
62
天
Bridging the gap between infection and detection: Biological, clinical, and health system contributors to diagnostic delay in HPV-associated cervical cancer
作者
Breanna R. Buhay; Jaeson D. Chin; Rachel Y. Han; Mark R. Wakefield; Yujiang Fang展开收起
作者单位
Department of Microbiology, Immunology & Pathology, Des Moines University, West Des Moines, IA 50266, United States; Department of Surgery, University of Missouri School of Medicine, Columbia, MO 65212, United States; Ellis Fischel Cancer Center, University of Missouri School of Medicine, Columbia, MO, 65212, United States展开收起
211
天
Multiple roles of circRNAs in cervical cancer: From fundamental carcinogenic mechanisms to clinical application prospects
作者
Miao Huo; Haitao Zhang; Yan Hua; Hong Qin; Wei Wang展开收起
作者单位
Department of Obstetrics and Gynecology, Second Hospital of Shanxi Medical University, Wuyi Road, Taiyuan, Shanxi Province 030001, China展开收起
22
天
Harnessing myeloid plasticity in CAR macrophages for solid tumor immunotherapy
作者
Zhun You; Zihan Lin; Yu Zhang; Libin Xu; Wen Zhang展开收起
作者单位
The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei 050011, China; Department of Gastrointestinal Surgery, the First Affiliated Hospital, Fujian Medical University, Fuzhou 350005, China; Department of immunology, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China; Department of Orthopedic Surgery, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China; Beijing Key Laboratory of Cell and Gene Therapy for Digestive System Cancers, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China展开收起
36
天
Hybrid membrane nanosystems for cancer immunotherapy: Biomimetic design, immune activation, and translational potential
作者
Ruihan Cao; Qianqian Wei; Si-si Yan; Caifeng Gong; Lin-lin Bu; Qiuji Wu展开收起
作者单位
School of Medicine, Wuhan University, Wuhan 430062, China; Department of Radiation and Medical Oncology, Hubei Key Laboratory of Tumor Biological Behavior, Hubei Provincial Clinical Research Center for Cancer, Zhongnan Hospital of Wuhan University, 169 Donghu Road, Wuhan 430071, China; Department of Oncology, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China; State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, Hubei Key Laboratory of Stomatology, Department of Oral & Maxillofacial - Head Neck Oncology, School & Hospital of Stomatology, Wuhan University, Wuhan 430079, China展开收起
FAQ
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY审稿要多久?
截至2026-11-19,CrushSCI 收录了 CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY 的 11 篇完整审稿记录。最快一篇从收稿到录用用了 22 天(Harnessing myeloid plasticity in CAR macrophages for solid tumor immunotherapy,2026-05-07 收稿,2026-05-29 录用),最慢一篇用了 240 天;平均 100.6 天,中位数 89 天。
Expert Matching · Case Demo
把投稿要求,转成可验证的期刊方案
说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。
